Analyst Price Target is $12.43
▲ +136.28% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Clarus Therapeutics in the last 3 months. The average price target is $12.43, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 136.28% upside from the last price of $5.26.
Current Consensus is
The current consensus among 7 polled investment analysts is to buy stock in Clarus Therapeutics.